Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
flatexDEGIRO AG

Start price
Target price
Perf. (%)
€19.10
14.09.21
€21.00
14.09.22
-12.57%
28.01.22

Could be worthwhile Investment >10% per year
buy
MBB SE

Start price
Target price
Perf. (%)
€136.20
14.09.21
€140.00
14.09.22
-29.44%
15.09.22

Could be worthwhile Investment >10% per year
Mutares SE & Co. KgaA

Start price
Target price
Perf. (%)
€27.90
14.09.21
€25.00
24.11.21
-21.51%
09.10.21

Could be worthwhile Investment >10% per year
buy
Baidu Inc. A ADR

Start price
Target price
Perf. (%)
€137.00
14.09.21
-
14.09.22
-9.20%
17.12.21

ROE higher than 15% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Small challenges to pay loans and raise capital
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€3.50
14.09.21
-
14.09.22
-30.29%
05.10.21

Innovative
buy
Uranium Energy Corp

Start price
Target price
Perf. (%)
€2.94
14.09.21
€7.40
14.09.22
2.50%
30.06.22

Could be very worthwhile Investment >20% year
positive Cash Flow expected
High Investments for future growth
Small challenges to pay loans and raise capital
buy
Centrotherm Photovoltaics AG

Start price
Target price
Perf. (%)
€5.02
14.09.21
-
14.09.22
17.13%
05.10.21

Future proof or reliable business model
buy
Alphabet Inc. C

Start price
Target price
Perf. (%)
€121.95
14.09.21
-
14.09.22
-12.87%
15.09.22

Very capable Management
Leading role in innovation
Good culture
Strong uniques
buy
Valneva SE

Start price
Target price
Perf. (%)
€11.82
14.09.21
-
14.09.22
-29.36%
15.09.22

buy
Valneva SE

Start price
Target price
Perf. (%)
€11.82
14.09.21
€30.00
14.09.22
-29.36%
15.09.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Future proof or reliable business model
Standard Investments for future growth
buy
Okta Inc.

Start price
Target price
Perf. (%)
€211.45
14.09.21
-
14.09.22
-70.86%
15.09.22

buy
Wacker Chemie AG

Start price
Target price
Perf. (%)
€156.15
14.09.21
-
14.09.22
-7.30%
15.09.22

buy
Mutares SE & Co. KgaA

Start price
Target price
Perf. (%)
€28.80
14.09.21
-
14.09.22
-46.11%
15.09.22

buy
Dermapharm Holding SE

Start price
Target price
Perf. (%)
€84.50
14.09.21
-
14.09.22
-50.67%
15.09.22

buy
PVA TePla AG

Start price
Target price
Perf. (%)
€34.35
14.09.21
-
14.09.22
-52.26%
15.09.22

buy
SGL Carbon SE

Start price
Target price
Perf. (%)
€10.46
14.09.21
-
14.09.22
-38.38%
15.09.22

buy
Lanson-Bcc

Start price
Target price
Perf. (%)
€26.80
13.09.21
€29.00
13.09.22
20.15%
14.09.22

Could be worthwhile Investment >10% per year
buy
Encavis AG

Start price
Target price
Perf. (%)
€15.18
13.09.21
€17.00
13.09.22
1.58%
03.10.21

Differentiated customer and product portfolio
Standard Investments for future growth
High valuation
Higher risks for its business
buy
Nordstrom Inc.

Start price
Target price
Perf. (%)
€22.88
13.09.21
€25.00
13.09.22
-18.96%
14.09.22

Could be worthwhile Investment >10% per year
ITM Power plc

Start price
Target price
Perf. (%)
€4.81
13.09.21
-
13.09.22
-63.35%
14.09.22

Sustainability is important
Probably not worthwhile Investment
Revenue decline/stagnation expected
Risky balance sheet
Plug Power Inc.

Start price
Target price
Perf. (%)
€19.74
13.09.21
-
13.09.22
1.48%
02.05.22

Revenue growth >5% per year expected
Probably not worthwhile Investment
Risky balance sheet
Lower EBIT Margin than peer group
Ballard Power Systems Inc.

Start price
Target price
Perf. (%)
€12.63
13.09.21
-
13.09.22
-35.85%
02.05.22

Standard Investments for future growth
Probably not worthwhile Investment
High valuation
Risky balance sheet
Valneva SE

Start price
Target price
Perf. (%)
€11.84
13.09.21
-
13.09.22
139.19%
29.11.21

Revenue growth >5% per year expected
Could be very worthwhile Investment >20% year
High valuation
Growths slower than the competition
buy
OceanaGold Corp.

Start price
Target price
Perf. (%)
€1.55
13.09.21
€1.55
13.09.22
-1.94%
14.09.22

Could be worthwhile Investment >10% per year
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€5.30
13.09.21
-
13.09.22
8.49%
19.09.21

Risky Investment